Takumi Kishimoto Selected Research

1-methyl-1-piperidinomethane sulfonate

11/2015	DNA copy number gains in malignant pleural mesothelioma.
12/2009	Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
11/2008	The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takumi Kishimoto Research Topics

Disease

43	Malignant Mesothelioma 01/2022 - 04/2003
26	Neoplasms (Cancer) 01/2022 - 04/2003
19	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2003
17	Mesothelioma 01/2022 - 04/2006
13	Pleural Effusion (Pleural Effusions) 10/2022 - 08/2005
10	Asbestosis 05/2016 - 10/2006
7	Pleurisy (Pleuritis) 01/2020 - 09/2008
7	Silicosis 03/2018 - 05/2006
5	Fibrosis (Cirrhosis) 01/2022 - 03/2011
4	Inflammation (Inflammations) 12/2019 - 03/2011
4	Adenocarcinoma 08/2017 - 12/2009
3	Pulmonary Atelectasis 04/2018 - 02/2002
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2011 - 10/2006
2	Pneumonia (Pneumonitis) 02/2022 - 03/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2019
2	Emphysema 01/2022 - 04/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 11/2004
2	Disease Progression 06/2019 - 01/2018
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2018 - 01/2015
2	Lymphoma (Lymphomas) 09/2018 - 01/2015
2	Carcinoma (Carcinomatosis) 02/2017 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2016 - 09/2011
2	Adenocarcinoma of Lung 11/2015 - 12/2009
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 09/2011
2	Neoplasm Metastasis (Metastasis) 03/2004 - 05/2002
2	Pulmonary Edema 04/2003 - 04/2003
1	Lymphopenia (Lymphocytopenia) 02/2022
1	Hematuria 02/2022
1	Lupus Nephritis 02/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Infections 02/2022
1	Leukopenia 02/2022
1	Proteinuria 02/2022
1	Hyperglycemia 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Myasthenia Gravis 01/2022
1	Pneumothorax 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lung Injury 11/2019
1	Rare Diseases (Rare Disease) 04/2019
1	Antisynthetase syndrome 09/2018
1	Hyperplasia 03/2018

Drug/Important Bio-Agent (IBA)

43	AsbestosIBA 10/2022 - 02/2002
5	Silicon Dioxide (Silica)FDA LinkGeneric 02/2022 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 08/2017 - 08/2005
3	Monoclonal AntibodiesIBA 01/2022 - 11/2019
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 06/2013
3	MesothelinIBA 01/2021 - 03/2010
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
3	Pemetrexed (MTA)FDA Link 01/2018 - 12/2011
3	1-methyl-1-piperidinomethane sulfonateIBA 11/2015 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 04/2006
3	MicroRNAs (MicroRNA)IBA 12/2013 - 08/2011
2	NivolumabIBA 06/2021 - 01/2018
2	Cell-Free Nucleic AcidsIBA 06/2019 - 12/2013
2	SurvivinIBA 03/2018 - 05/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 05/2017
2	Messenger RNA (mRNA)IBA 08/2017 - 11/2006
2	ParaffinIBA 08/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 08/2017 - 01/2017
2	Claudin-4IBA 02/2017 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2012 - 03/2009
2	Carboplatin (JM8)FDA LinkGeneric 01/2012 - 12/2011
2	Serpentine Asbestos (Chrysotile)IBA 09/2011 - 10/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 11/2006
2	CytokinesIBA 07/2009 - 08/2007
1	anti-dsDNA autoantibodyIBA 02/2022
1	Antiviral Agents (Antivirals)IBA 02/2022
1	CreatinineIBA 02/2022
1	durvalumabIBA 01/2022
1	acrylic acid (acrylate)IBA 01/2022
1	tremelimumabIBA 01/2022
1	PolymersIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	Secretory Leukocyte Peptidase InhibitorIBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2019
1	ChemokinesIBA 12/2019
1	LigandsIBA 12/2019
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2019
1	Glycoproteins (Glycoprotein)IBA 11/2019
1	Pharmaceutical PreparationsIBA 11/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2018
1	Methotrexate (Mexate)FDA LinkGeneric 09/2018
1	tremolite (bredigite)IBA 09/2017
1	RNA (Ribonucleic Acid)IBA 08/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2017

Therapy/Procedure

9	Therapeutics 02/2022 - 03/2004
8	Drug Therapy (Chemotherapy) 05/2017 - 05/2002
4	Radiotherapy 01/2016 - 05/2002
2	Chemoradiotherapy 05/2017 - 03/2011
2	Pneumonectomy (Lung Volume Reduction) 05/2016 - 01/2015
1	Immunotherapy 11/2019
1	Traction 04/2018
1	Pleurodesis 03/2018
1	Length of Stay 03/2018
1	Chest Tubes (Chest Tube) 03/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018